Purdue Pharma Shuts Down After $7.4B Opioid Settlement, Pharmacists to Lead New Accountability Era

A landmark court-approved restructuring saw Purdue Pharma cease operations on May 1, 2026. Its assets now transfer to Knoa Pharma LLC, a public benefit entity with strict marketing bans. Under the $7.4 billion settlement, Purdue and the Sackler family will fund addiction treatment, prevention and harm reduction programmes across all states. Over 30 million internal documents will be made public under independent oversight. Public health experts caution that the opioid crisis persists, driven by synthetic opioids like fentanyl. The new framework positions pharmacists at the frontline for risk detection, naloxone distribution and patient education as community programmes receive fresh funding.

Use The App To Win ₦1m

Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.